GCP (Good Clinical Practice)

GCP (Good Clinical Practice) - Axcellant

GCP (Good Clinical Practice)

  1. lut 28, 2025

What Does the 'GCP (Good Clinical Practice)’ Mean?

GCP, or Good Clinical Practice, is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human subjects. It provides assurance that the rights, safety, and well-being of trial participants are protected, and that clinical trial data are credible.

GCP guidelines were developed by the International Conference on Harmonisation (ICH) and are used by regulatory authorities worldwide. Adherence to GCP principles ensures that clinical research is conducted to the highest standards, promoting public confidence in clinical research and facilitating the acceptance of clinical data by regulatory authorities.

Why Is the 'GCP (Good Clinical Practice)’ Important in Clinical Research?

GCP is crucial in clinical research as it establishes a unified standard for conducting trials across different countries and institutions. This standardization ensures that data from various studies can be compared and combined, enhancing the overall quality and reliability of clinical research outcomes.

Additionally, adherence to GCP principles protects the rights, safety, and well-being of trial participants, which is fundamental to ethical research practices. It also increases the credibility of study results, making them more likely to be accepted by regulatory authorities for drug approvals and treatment recommendations.

Good Practices and Procedures

  1. Implement a robust quality management system that includes standard operating procedures (SOPs) for all aspects of clinical trial conduct and documentation.
  2. Establish an independent data monitoring committee to review safety data and study progress at predetermined intervals.
  3. Conduct thorough investigator and site qualification processes, including pre-study visits and ongoing monitoring of site performance.
  4. Develop and maintain a comprehensive risk-based monitoring plan that adapts to emerging data and identified issues throughout the trial.
  5. Implement a validated electronic data capture system with audit trails to ensure data integrity and traceability of any changes made during the study.

Related Terms

Resources

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…

Axcellant at ICNC Berlin: Following the Future of Nuclear Cardiology – and helping bring it to clinical reality

The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…